Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Fatima Stanford, an obesity specialist at Harvard Medical School, told the Times that "individuals who agree to reduce treatment frequency may already be more adherent, more confident in their behaviors or metabolically more responsive."About 12% of patients who tried spacing out injections eventually went back to weekly doses after gaining weight back.Still, Stanford said the study does "reframe the conversation." "Chronic treatment does not necessarily mean maximal weekly dosing forever. More individualized dosing plans may be more effective, she added.GLP-1 drugs such as Wegovy and Ozempic have transformed obesity treatment
GLP- for weight loss are not for everyone
The incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), play pivotal roles in this regard
Gives effective results
Fernando Sende is a double board certified doctor specializing in weight loss injections
Tracking progress effectively Subjective assessment misleads
